Get startedLog in
    Picture of Novo Nordisk A/S logo

    NOVO B — Novo Nordisk A/S News Story

    0.000.00%
    dk flag iconLast trade - 00:00
    HealthcareSpeculativeLarge CapNeutral
    All News

    Brief: Nanexa And Novo Enter Global License, Collaboration Deal

    Picture of Novo Nordisk A/S logoNovo Nordisk A/S
    25/09/2026 07:56
    BRIEF-Nanexa And Novo Enter Global License, Collaboration Deal 
    Sept 25 (Reuters) - Nanexa AB NANEXA.ST:
    • SAID ON THURSDAY CO AND NOVO NORDISK ENTER GLOBAL LICENSE, COLLABORATION DEAL WORTH UP TO EUR 1.165 BLN
    • DEAL COVERS UP TO FIVE PROGRAMS, TARGETS MONTHLY AND QUARTERLY DOSING FOR OBESITY, DIABETES DRUGS
    • EUR 615 MLN OF DEAL VALUE COMPRISES UPFRONT, DEVELOPMENT AND REGULATORY MILESTONES

     Source text for Workspace: nMFNc51q1r
     Further company coverage: NANEXA.ST 

     (Gdansk Newsroom)
     ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Novo Nordisk A/S

    See all news